Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an older maintenance notice (v3.4.1) was removed; the changes pertain to site version updates and operating status notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide notice regarding government funding and the NIH Clinical Center status, and updated the release to Revision: v3.4.1 while removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe page adds a 'Show glossary' option and updates the descriptions of color-coded highlights. Revision notes are updated to v3.4.0 and the No FEAR Act data wording is adjusted.SummaryDifference0.9%

- Check42 days agoChange DetectedNew historical revision label v3.3.4 has been added, replacing the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history shows a new revision label (v3.3.3) added and the HHS Vulnerability Disclosure and Revision: v3.3.2 removed as administrative disclosures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the record history; these are minor version history updates on the page and do not affect study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.